Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
158.73
-4.33 (-2.66%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Belite Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6,244 | 6,001 | 1,948 | 1,263 | 750 | - | |
| Market Cap Growth | 241.76% | 207.98% | 54.32% | 68.44% | - | - | |
| Enterprise Value | 5,752 | 5,726 | 1,861 | 1,221 | 701 | - | |
| Last Close Price | 158.73 | 159.96 | 63.10 | 45.75 | 30.14 | - | |
| PB Ratio | 8.10 | 7.79 | 13.36 | 13.96 | 18.06 | - | |
| P/TBV Ratio | 8.10 | 7.79 | 13.37 | 13.96 | 18.06 | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | - | |
| Net Debt / Equity Ratio | -0.64 | -0.64 | -0.99 | -0.96 | -0.99 | -1.04 | |
| Net Debt / EBITDA Ratio | 5.86 | 5.86 | 3.63 | 2.77 | 3.23 | 1.78 | |
| Net Debt / FCF Ratio | 13.24 | 13.24 | 4.93 | 2.92 | 3.48 | 2.30 | |
| Quick Ratio | 49.90 | 49.90 | 24.09 | 24.50 | 20.01 | 10.61 | |
| Current Ratio | 50.02 | 50.02 | 24.31 | 24.76 | 20.35 | 10.66 | |
| Return on Equity (ROE) | -16.94% | -16.94% | -30.60% | -47.95% | -43.45% | -46.60% | |
| Return on Assets (ROA) | -11.29% | -11.29% | -20.26% | -28.50% | -25.59% | -27.78% | |
| Return on Capital Employed (ROCE) | -10.90% | -10.90% | -27.40% | -34.80% | -30.40% | -58.60% | |
| Earnings Yield | -1.24% | -1.29% | -1.85% | -2.50% | -1.69% | - | |
| FCF Yield | -0.60% | -0.62% | -1.51% | -2.37% | -1.58% | - | |
| Buyback Yield / Dilution | -9.82% | -9.82% | -14.83% | -33.12% | -108.74% | -8.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.